Granules India Limited (BOM:532482)
India flag India · Delayed Price · Currency is INR
491.95
+24.60 (5.26%)
At close: Aug 29, 2025

Granules India Company Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products.

The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions.

In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives.

The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral.

Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Granules India Limited
CountryIndia
Founded1984
IndustryPharmaceutical Preparations
Employees4,066
CEOKrishna Chigurupati

Contact Details

Address:
Granules Tower
Hyderabad, 500084
India
Phone91 40 6904 3500
Websitegranulesindia.com

Stock Details

Ticker Symbol532482
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2834

Key Executives

NamePosition
Krishna ChigurupatiChief Executive Officer
Mukesh SuranaChief Financial Officer